Replies to post #413952 on Anavex Life Sciences Corp (AVXL)

[bas2020]

I guess you missed the CTAD results where all endpoints were met and patients actually improved (SUPER RESPONDERS)... an actual disease-modifying drug... in pill form.

[williamssc]

ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,

SHOWING STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN GLOBAL CLINICAL STUDY OF PATIENTS WITH EARLY ALZHEIMER’S DISEASE

What data/numbers are you looking for.